rewirebio.iobenchmarks
Dataset

Talos 4,735 unresolved individuals

Prospective research and clinical programme after earlier unresolved testing; 29 staggered monthly cycles, each cohort at least three.

Evaluation results

1 evaluation · 14 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
5.1% Diagnostic yield (additional yield from reanalysis)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Review of Talos output
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
221 Count (diagnoses: first cycle)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
92% Proportion (diagnoses: first cycle)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
109 Count (diagnoses: improved analysis)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
45% Proportion (diagnoses: improved analysis)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
20 Count (diagnoses: later cycles)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
8% Proportion (diagnoses: later cycles)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Twenty-nine cycles
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
5 New candidates per 1000 cases per cycle
variants-per-1000-cases-per-cycle · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning During iterative reanalysis
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
241 Count (diagnoses: new confirmed)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Review of Talos output
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
78 Count (diagnoses: new gene-disease evidence)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
32% Proportion (diagnoses: new gene-disease evidence)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
54 Count (diagnoses: new variant evidence)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
22% Proportion (diagnoses: new variant evidence)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning More than half
Configuration: Talos monthly iterative reanalysis with clinical confirmationProtocol: Talos programme reanalysis yield
Dataset: Talos 4,735 unresolved individuals
238 Count (newly diagnosed individuals)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Talos monthly reanalysis programme

Not reported

Aggregation: Not reported

Automated reanalysis of genomic data for rare disease diagnostics at scale · Results, Iterative reanalysis, paragraph beginning Review of Talos output

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

6 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Eligible individuals
4735
Context-only references
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.eligible_individuals

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Initial test years
2017–2022
Context-only references
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.initial_test_years

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Private data not included
true
Context-only references
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.private_data_not_included

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Reanalysis period
2023–2025
Context-only references
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.reanalysis_period

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Prospective research and clinical programme after earlier unresolved testing; 29 staggered monthly cycles, each cohort at least three.
Context-only references
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
Talos 4,735 unresolved individuals
Context-only references
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-reanalysis-4735-data.

Related records

Suggest a correction